The pillars of our work.
Sustainability and Green Chemistry
By enabling our clients to produce their high-value chemicals in a sustainable and cost-effective way, we strive to make a positive impact on the environment. Our focus on enzyme immobilization allows us to offer enhanced natural catalysts that are more efficient and environmentally friendly than traditional synthetic catalysts.
Continuous improvement
As we gather more data from the development of the catalog or services, we can improve our prediction capabilities and produce better products. This, in turn, feeds back into our bioinformatic tools, creating a positive feedback loop that is crucial to our development.
Technology
Driven
Our use of AI-driven tools allows us to de-risk the process and develop immobilized enzymes quickly and reliably. Our bioinformatic workflow predicts enzyme immobilization and feeds data into AI approaches. We analyze the physicochemical characteristics, 3D structure, surface properties, dynamic behavior, and reactivity of enzymes to control their orientation and improve their stability.
The Chemical Industry today.
520mn
Market value
500k
Biocatalytic Reactions
3.1bn
CO2 reduction
2.4mn
Products affected
In our modern society, chemicals have become indispensable components of our daily routines. However, with this increasing reliance on chemicals comes a pressing challenge – how can we fulfill the growing demand while ensuring environmental preservation?
At inSEIT, we have embraced this challenge as an opportunity to shape a more sustainable future.
We recognize the immense potential of immobilized biocatalysts and we firmly believe that the potential of immobilized biocatalysts remains largely untapped due to the small number of available tools and the lack of comprehensive approaches. Rooted in sustainability, and through our innovative approach, we want to make immobilized enzymes the future standard toolbox for chemical industries. Adopting our solutions, our clients can embrace cleaner and more eco-friendly alternatives without compromising their productivity or quality.
​
David Roura Padrosa, PhD - CEO and co-founder
Biocatalysis
Consultancy
We envisage our clients to come with a reaction of interest – the making of a specific chemical product - or a specific enzymatic reaction they want to apply.
Bioinformatic
Analysis
Bioinformatic workflow to predict enzyme immobilization and a database to feed AI approaches. CapiPy is based on an open-source software we developed in 2021.
Immobilization screening
Our novel screening platform is a state-of-the-art technology that enables us to match the appropriate immobilized enzyme to the desired application.
Enzyme Immobilization
We offer a variety of immobilization strategies and we ensure that the selected one matches the needs of the process.
Synthesis Development
We design novel biocatalytic processes using immobilized enzymes to produce products and scale them to the gram scale.
Oxidoreductases
Dehydrogenases and reductases, for any of your key steps and couple it with a cofactor regeneration!
Transferases
Synthesize chiral amines and more with our immobilized transferases with various selectivities.
Cofactor recycling
Enhance the cost-efficiency and speed of your bioreactions incorporating a recycling system.
The company
In 2021, a pioneering bio-technology startup emerged from the University of Bern. Founded by visionary students and professors, this innovative company harnessed the university's expertise to revolutionize the field of bio-technologies. With a strong emphasis on collaboration and cutting-edge research, the startup quickly garnered attention and investment, paving the way for transformative advancements in the realm of life sciences.
Who believes in us.
January 2022
Johnson Matthey
July 2022
Bridge Proof of Concept
August 2022
Venture Kick
Selected to participate in an international accelerator organized by Johnson Matthey and The Bakery.
Funding agency of the Innosuisse and Bridge programmes to develop a promising technology towards a market application.
Competition organized by VentureLabs to promote young academics to gap the Bridge between academia and market. Funded with 50K.
December 2022
Ypsomed Innovation
Selected finalist for the prestigious Ypsomed award, recognizing the potential of such a young start-up in the biotech space.
June 2023
Nucleate
inSEIT was awarded two prizes in the first programme of the Nucleate Activator in Switzerland. Scientific Excellence and Novel Idea Award.
July 2023
Bern Economic
Development Agency
The Bern Economic Development Agency supports novel and promising start-ups based in the Berner Oberland.
October 2023
inSEIT
We closed our first financing round, supported by Value Maker and VentureLabs. Together with the non-dilutive funding from Innosuisse and Bridge (Bridge Proof of Concept) and the support from the Berninvest we raised over CHF 390K.
March 2024
inSEIT
inSEIT was selected as one of the 10 start-ups to participate on the Venture Leaders Biotech 2024.